Inflammatory Markers and Plasma Lipids in HIV Patients: A Correlation Analysis Study
Authors:
Open Access
- 28 December 2017
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Biochemistry Journal
- Vol. 11 (1) , 105-118
Abstract
Inflammatory Markers and Plasma Lipids in HIV Patients: A Correlation Analysis StudyKeywords
This publication has 43 references indexed in Scilit:
- Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor–Based Initial Antiretroviral Therapy Among HIV-Infected IndividualsThe Journal of Infectious Diseases, 2015
- Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patientsBMC Infectious Diseases, 2014
- Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapyNigerian Medical Journal, 2013
- HIV as a risk factor for cardiac disease in Botswana: a cross-sectional studyInternational Health, 2012
- HIV Infection, Inflammation, Immunosenescence, and AgingAnnual Review of Medicine, 2011
- Inflammation, immune activation, and HIV.2010
- Serum Levels of TNF‐α, IFN‐γ, IL‐6, IL‐8,IL‐12, IL‐17, and IL‐18 in Patients With Active Psoriasis andCorrelation With Disease SeverityMediators of Inflammation, 2005
- CDC/AHA Workshop on Markers of Inflammation and Cardiovascular DiseaseCirculation, 2004
- IL-10 in HIV infection: increasing serum IL-10 levels with disease progression—down-regulatory effect of potent anti-retroviral therapyClinical and Experimental Immunology, 1999
- PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) AND INTERLEUKIN-1 (IL-1) IN PATIENTS WITH AIDS - ENHANCED LEVEL OF TNF-ALPHA IS RELATED TO A HIGHER CYTO-TOXIC ACTIVITY1989